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Background: A series of different rubella vaccination strategies were implemented to control rubella and prevent
congenital rubella virus infection in Beijing, China. The rubella vaccine was available in 1995 in Beijing, and was
introduced into the Beijing immunization program (vaccine recipients at their own expense vaccination) in 2000,
and was introduced into the National Expanded Program on Immunization (vaccine recipients free vaccination)
in 2006. Rubella virological surveillance started in Beijing in 2007.
Results: The reported rubella incidence rate has decreased dramatically due to the introduction of the vaccine in
Beijing since 1995. However, rubella epidemics occurred regardless in 2001 and 2007. The incidence rate among
the floating population has gradually increased since 2002, reaching 2 or more times that in the permanent
resident population. The peak age of rubella cases gradually changed from <15 years of age to adults after 2005.
Phylogenetic analysis was performed and a phylogenetic tree was constructed based on the World Health
Organization standard sequence window for rubella virus isolates. All Beijing rubella virus isolates belong to
genotype 1E/cluster1 and were clustered interspersed with viruses from other provinces in China. The effective
number of infections indicated by a Bayesian skyline plot remained constant from 2007 to 2011.
Conclusions: The proportion of rubella cases among the floating population has increased significantly in Beijing
since 2002, and the disease burden gradually shifted to the older age group (15- to 39-year olds), which has
become a major group with rubella infection since 2006. Genotype 1E rubella virus continuously caused a rubella
epidemic in Beijing in 2007–2011 and was the predominant virus, and all Beijing genotype 1E viruses belong to
cluster 1, which is also widely circulated throughout the country.
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Rubella infection usually presents as a mild or asymp-
tomatic infection in children and adults. However, the
rubella virus is a potent, highly infectious, and terato-
genic agent that may cross the placenta and cause fetal
infection; such infection in the first trimester of preg-
nancy can result in miscarriage, fetal death, or an infant* Correspondence: wenbo_xu1@yahoo.com.cn; pxh@bjcdc.org
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reproduction in any medium, provided the orborn with serious birth defects including hearing impair-
ment, cataracts, and cardiac defects, collectively known
as congenital rubella syndrome (CRS) [1,2]. To prevent
congenital rubella infection including CRS, the World
Health Organization (WHO) recommended the intro-
duction of a rubella-containing vaccine (RCV) in na-
tional childhood immunization schedules in 2000 [3].
Since then, the number of reported rubella cases has
dramatically decreased worldwide [4].
The rubella virus is the single member of the Rubivirus
genus in the Togaviridae family. Rubella virus has an
enveloped, single-stranded, positive-polarity RNA gen-
ome consisting of 9,762 nucleotides (nt) that contains a
5′-proximal open reading frame (ORF) that encodes
nonstructural polypeptides (p150 and p90) responsible
for viral genome replication as well as a 3′-proximaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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E1) [1,5]. A 739-nucleotide region (nt8731–9469) within
the E1 gene was recommended as a standard genotyping
window for assigning genotypes by comparison with the
reference virus sequences [6]. Although rubella is a sero-
logically monotypic virus [1], recent sequence analysis
revealed that distinct genetic variants of rubella viruses
exist [7]. To date, 2 clades (1 and 2), 9 genotypes
(1B, 1C, 1D, 1E, 1 F, 1G, 2A, 2B, and 2C), and 4
provisional genotypes (1a, 1 h, 1i, and 1j) have been
identified [7]. The genotype 1E and 2B viruses had wide
geographic distribution and were frequently found in the
world in recent years [8]. In addition, genotype 1E was
the predominant genotype circulated in China since it
was first found in 2001 [9,10].
Beijing, the capital city of China, covers an area of only
16,800 square kilometers and is composed of 14 districts
and 2 counties and has a large population of more than
19.72 million individuals (data from Chinese Statistics Bur-
eau in 2011), including more than 12.46 million permanent
resident populations (the population of habitual residence
in Beijing, including the provisional go out population) and
approximately 7.26 million floating populations (the popu-
lation of internal migration who leave the domicile and live
in Beijing for the purpose of work or others). It is expected
that the number of floating population in Beijing will con-
tinue to increase in the next 20 years.
In 1989, rubella including CRS was classified as a cat-
egory C notifiable infectious disease by the Ministry of
Health of China; rubella incidence data have been avail-
able in Beijing ever since. And in 2007, rubella viro-
logical surveillance started in Beijing started. In 2011,
the CRS surveillance projects were initiated and spon-
sored by the Beijing Municipal Health Bureau in order
to elucidate the disease burden of CRS, and in the CRS
prevention stage, disease surveillance was focus on
detecting cases of CRS.
To control rubella and prevent congenital rubella virus
infection, a series of different rubella vaccination strategies
were implemented in Beijing. In the first stage from 1995
to 1999, the rubella vaccine, including a domestic MMR
vaccine containing rubella vaccine strain BRDII and an
imported MMR vaccine containing rubella vaccine strain
RA27/3, have been available in Beijing since 1995. In the
second stage from 2000 to 2005, the rubella vaccine was
introduced into the Beijing immunization program (vac-
cine recipients at their own expense vaccination), and the
target population included 17-month-old children; 7-, 12-,
and 16-year-old students; and new students in the univer-
sity from outside of Beijing to cover all populations under
20 years of age in Beijing. In the third stage from 2006 to
the present, a 2-dose schedule with the measles-mumps-
rubella (MMR) vaccine was administrated to children at
1.5 years of age and 6 years of age, and the primaryimmunization dose was adjusted to 8 months of age in
2008 when the rubella vaccine was formally introduced to
the national Expanded Program on Immunization (vaccine
recipients free vaccination). That means all the children
under 6 years of age have had the opportunity to be vacci-
nated (vaccinated three times at 1, 2 and 3 years of age)
against the rubella virus free of cost since 2006.
Given that little is known about the rubella epidemic in
Beijing, here, we provide an overview (from 1990 to date)
of the rubella epidemiology in this city that has a high pro-
portion of floating populations. In addition, although case-
based rubella surveillance was integrated into the measles
laboratory network in Beijing in 2005, rubella virological
surveillance was started in 2007, and in this study, the cir-
culation pattern of rubella viruses was investigated during
the past 5 years to establish an important genetic baseline
in Beijing during the rubella control stage.
Results
Overview of rubella epidemiology in Beijing
During 1990–1994, the reported rubella incidence rate
remained at a high level, peaking at 166.69/100,000 in
1994. Soon after, the reported incidence rate dramatic-
ally decreased along with the usage of the rubella vac-
cine in Beijing since 1995. However, rubella epidemics
also occurred in 2001 (reported rubella cases: 9638;
reported peak annual incidence rate, 69.58/100,000) and
in 2007 (reported rubella cases: 1664; reported peak an-
nual incidence rate, 10.19/100,000) (Figure 1a). Before
2001, the rubella incidence rate in the permanent resi-
dent population was almost the same or slightly higher
than that in the floating population; on the contrary, the
incidence rate among the floating population has grad-
ually increased since 2002, reaching 2 or more times that
of the permanent resident population (Figure 1b). Data
pertaining to the rubella incidence rate of the permanent
resident population and floating population in 2004 were
not available.
The reported rubella cases were concentrated in pa-
tients <15 years of age before 2005 (>59.7%) except for
2003 (42.4%). However, the proportion of reported ru-
bella cases within the 15- to 39-year-old age group in-
creased each year from 1998 (20.2%) to 2011 (85.6%),
and the 15- to 39-year-old age group became a major
group with rubella infection between 2006 and 2011
(52.0%, 65.2%, 72.7%, 70.9%, 78.5%, and 85.6%, respect-
ively, for each of these years) (Figure 2). The CRS sur-
veillance project were initiated in order to elucidate the
disease burden of CRS in 2011 in Beijing, and only 1
CRS case was captured and was confirmed by the la-
boratory through the surveillance system.
Rubella seroepidemiology analyses were performed in
2003 (2211 people including 1035 immigrants were
recruited) and in 2007 (2003 people including 923
Figure 1 Reported rubella cases in Beijing, China since 1990. (a) Total rubella cases and the incidence rate in Beijing by year of onset, from
1999 to 2011. The numbers above the bars represented the number of reported rubella cases / the incidence rate. (b) Comparison of the rubella
incidence rate between the permanent resident and floating populations by year of onset, from 1997 to 2011. Data pertaining to the rubella
incidence rate of the permanent resident and floating populations in 2004 were not available.
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2003 among permanent resident population and floating
population were 24.4% and 30.8%, respectively. The sero-
negativity of rubella antibodies for permanent resident
population remained stable (25.6%), while it decreased to
28.0% for floating population in 2007.
Genotype 1E rubella virus continuously caused a rubella
epidemic in Beijing
A total of 64 rubella viruses were isolated from throat
swabs in all 16 districts/counties in 2007–2011, includ-
ing 1 virus that was isolated from a lab-confirmed CRS
case (Figure 3). All viruses were named according to
WHO systematic nomenclature for rubella viruses. The
sequences of the 739-nt region within the E1 gene of the
64 rubella virus isolates and 32 WHO reference strains
were used for phylogenetic analysis (Figure 4a). All Beijing
rubella virus isolates belong to genotype 1E (Figure 4a),which indicated that genotype 1E continuously caused a
rubella epidemic in the past 5 years in Beijing. The nucleo-
tide and amino acid sequence identity among these viruses
was 97.2%–100% and 97.9%–100%, respectively. Multiple
different clusters existed among Beijing rubella viruses in
2007–2008. Beijing rubella viruses isolated in 2009–2011
were quite similar (>98.5%) and had high similarity with
some of the viruses during 2007–2008.
To determine the molecular epidemiology of the Beijing
rubella virus strains, a phylogenetic dendrogram was
constructed that contained 16 randomly selected Beijing
rubella virus strains (3 strains in 2007, 3 strains in 2008, 2
strains in 2009, 3 strains in 2010, and 5 strains in 2011 se-
lected) based on the their nucleotide divergence, lineage
resolution and sampling time as indicated in Figure 4a, 57
strains from 19 provinces in mainland China in 2001–
2009, and 22 strains from 16 other countries in 1995–
2011 (Figure 4b and Table 1). Similar to the most rubella
Figure 2 Rubella incidences in different age groups in Beijing, China since 1991. As reported by the case-based rubella surveillance system
of the Beijing Center for Disease Prevention and Control.
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Beijing rubella virus strains clearly belonged to genotype
1E/cluster1 and were interspersed with viruses from 19
provinces in China and from Russia (2006), the United
States (2008), and Japan (2010 and 2011).Figure 3 Geographic distribution of 64 genotype 1E rubella viruses isBoth the strict and relaxed clock models were
implemented using the Bayesian skyline model for popu-
lation growth, the latter being preferred. A Bayesian sky-
line plot (BSP; Figure 5) showed that the effective
number of infections remained constant in 2007–2011.olated in Beijing, China, from 2007 to 2011.
Figure 4 Phylogenetic analyses of sequences of the Beijing rubella viruses based on the World Health Organization (WHO) standard
sequence window. (a) Phylogenetic analysis of 64 Beijing rubella virus sequences in 2007–2011 compared with 32 WHO reference sequences.
The symbols with different colors represent rubella viruses isolated in different years. The 16 rubella viruses in red were selected for further
molecular epidemiological analysis. (b) Phylogenetic analysis of 16 representative Beijing genotype 1E rubella virus strains compared with 57
genotype 1E rubella viruses from the other provinces of China in 2001–2009 and 22 viruses from 16 other countries. The genotype 1E rubella
virus sequences other than Beijing were obtained from the GenBank database. The Chinese vaccine strain BRD II was used as an outgroup.
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An overview of the rubella epidemiology in Beijing was
provided in this study. The rubella epidemic cycles oc-
curred approximately every 6–7 years (1994, 2001, and
2007), a trend that was similar to the national trend
[10]. With the introduction of the rubella vaccine in1995, a significant reduction in rubella morbidity has oc-
curred, and the incidence rate has remained at a rela-
tively low level. However, the proportion of rubella cases
among the floating population has increased significantly
since 2002, which may be due to high migration and
tourism rates over the past 10 years. In addition,
Table 1 Genotype 1E virus strains from 16 countries other than China used in this study
Virus isolate Isolation country and year GenBank accession no. Reference
RVs/Caen.FRA/23.95/1E France, 1995 FN546967 [11]
FRI-BAH97 Bahamas, 1997 AY326359 [12]
DES/MB-CAN97 Canada, 1997 AY326358 [12]
6423/PV-ITALY-1997 Italy, 1997 AY161374 [12]
S633-SUR98 Suriname, 1998 AY326363 [12]
G432-GER99 Germany, 1999 AF551761 [12]
CAB/NY-USA00 USA, 2000 AY326355 [12]
M1-MAL-2001 Malaysia, 2001 AY968211 [6]
RVs/TUN/7.03[1E] Tunisia, 2003 FN547014 [11]
Rvi/Deweim.SDN/24.05[1E]CRS Sudan, 2005 FJ775000 [13]
RVi/Minsk.BLR/18.05/2[1E] Belarus, 2005 AM258955 [14]
RVs/London.GBR/08.05[1E]CRS UK, 2005 EF210051 [15]
RVs/Lille.FRA/25.05[1E] France, 2005 FN547019 [11]
RVi/Moscow.RUS/03.06[1E] Russia, 2006 FJ711682
RVi/Almaty.KAZ/13.06[1E] Kazakhstan, 2006 FJ711684
RVs/Chernivtcsi.UKR/13.07[1E] Ukraine, 2007 FJ711683
RVi/Pullman.WA.USA/30.08[1E] USA, 2008 JN635288
RVi/BarHarbor.ME.USA/43.08[1E] USA, 2008 JN635286
RVi/Vladimir.RUS/9.08[1E] Russia, 2008 FJ711681
RVi/Toyama.JPN/31.10[1E] Japan, 2010 AB646368
RVs/Kawasaki.JPN/17.11/2[1E] Japan, 2011 AB674471
RVi/Hokkaido.JPN/20.11/1[1E] Japan, 2011 AB683468
Figure 5 Bayesian skyline plot obtained by analyzing the 16 genotype 1E rubella virus sequences. Ordinate: the number of effective
infections at a given time; abscissa: time (in years). The thick solid line represents the median, while the blue area represents the 95% highest
posterior density of the number of effective infections at the time estimates.
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ceptibility to rubella among the floating population was
28%; therefore, as the size of the floating population in-
creases in the near future, it is necessary to take effective
measures to improve RCV coverage among these people,
otherwise rubella control in Beijing may be impeded.
Reported rubella cases were concentrated in patients <
5 years of age before 2005, while the disease burden
gradually shifted to the older age group (15- to 39-year
olds), which has remained a major group with rubella in-
fection since 2006. The occurrence of this phenomenon
may due to the low vaccine coverage in Beijing at that
time. Low coverage might alter the rubella virus trans-
mission dynamics and could increase the average age of
rubella infection for females from childhood to the
childbearing age group, meaning that the risk for CRS
might increase [4]. Such a shift in susceptibility of older
age groups occurred and was documented in Greece and
South Africa as well [16,17]. Therefore, following the
WHO recommendations, regions or countries attempting
rubella control and elimination should ensure that routine
vaccine coverage in children is >85% and sustainable in
the long term to ensure rubella immunity among women
of reproductive age [3,18].
Since the rubella incidence rate has become much
higher among the childbearing age group in recent years
in Beijing, the disease burden of CRS needed to be eluci-
dated; thus, CRS surveillance projects were initiated and
sponsored by the Beijing Municipal Health Bureau in
2011. To date, only 1 CRS case was captured through
the surveillance system. Birth defects including a cata-
ract in the left eye and rubella-specific IgM antibody
were detected after birth in this individual. Phylogenetic
analysis indicated that the rubella virus of predominant
genotype (genotype 1E) caused the congenital infections.
Although CRS surveillance is challenging because of the
difficulty of diagnosis and reporting in settings with lim-
ited medical resources, ongoing CRS surveillance is ne-
cessary. A comprehensive and high-quality program
including CRS surveillance, integrated rubella surveil-
lance in measles case-based surveillance, and a well-
functioning routine immunization program are needed
to fully understand the burden of rubella and CRS [4]
and determine the most appropriate strategies for ru-
bella control and CRS prevention in Beijing. In addition,
effective routine rubella and CRS surveillance has not
yet been established in China; therefore, a successful ex-
perience with rubella and CRS surveillance in Beijing
could be extended to the entire country in the future.
The WHO Global Measles and Rubella Laboratory
Network was developed in 2000 and currently includes
690 laboratories serving 183 countries including China
[19]. An important aspect of laboratory surveillance for
measles and rubella is the genetic characterization ofcirculating wild-type viruses to support molecular epide-
miologic studies [19]. In Beijing, rubella virological sur-
veillance was integrated into the measles surveillance in
2007, and 5-year consecutive surveillance indicated that
the predominant genotype 1E rubella virus continuously
caused a rubella epidemic in Beijing in the past 5 years.
Between 2007 and 2008, multiple transmission chains
of genotype 1E rubella viruses were found in different
districts/counties of Beijing, while some transmission
chains of genotype 1E faded, and viruses with similar se-
quences continued circulating in various districts/coun-
ties in the following 3 years. This might be related to the
large-scale use of the rubella vaccine since 2006, when
the rubella vaccination was provided free of charge to all
children in Beijing. Vaccination may have interrupted
some transmission chains of the rubella virus, while
some genotype 1E strains during 2007–2008 survived
and continued circulating in 2009–2011.
Effective population size determines the strength of
genetic drift and the frequency of co-infection by mul-
tiple genotypes, making it a key factor in viral evolution.
Viral evolutionary dynamics on different spatiotemporal
scales will be largely determined and constrained by effect-
ive population size. For viruses, effective population size
can be considered as the average number of horizontally
transmitted virions in an idealized population, and it will
determine how strong genetic drift – one of the key evolu-
tionary forces – acts on viral populations [20,21].
To estimate virus effective population sizes through
time, we used a coalescent -based approach that can in-
dependently estimate effective population sizes, and this
approach is implemented in a Bayesian Markov Chain
Monte Carlo (MCMC) inference framework in the pro-
gram Bayesian evolutionary analysis sampling trees
(BEAST) [22]. The phylogeny and divergence times of
the genotype 1E rubella virus lineages using a standard
sequence window sampled at different times were in-
ferred using a relaxed molecular clock model in non-
parametric BSP method, which is a useful analysis based
on coalescent theory seeks to predict the amount of time
elapsed between the introduction of a mutation and the
arising of a particular gene distribution in a population.
Effective population size can be defined as the census
population size divided by the variance in the number of
offspring among individuals. In the case of a virus, the
census population size is estimated from isolate counts,
whereas the effective population size is actually an esti-
mate of the effective number of infections, that is, those
that go on to produce subsequent infections [23,24].
The results showed that the rubella virus population
size in Beijing remained constant in 2007–2011, al-
though a free 2-dose schedule with MMR was adminis-
trated in 2006 and a free 3-dose schedule with MMR
was administrated since 2008. The results indicated that
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since 2007 and are the predominant genotype in Beijing.
Compared with the situation of the rubella virus popula-
tion size nationwide, the epidemic started a decline that
led to a decrease in the effective population size along
with the introduction of rubella vaccine into the Na-
tional Expanded Program on Immunization [10], this is
obviously different and may be due to the migration to
Beijing from other provinces, resulting in a high propor-
tion of floating population, among which the rubella vac-
cine coverage may be much lower.
Chinese genotype 1E viruses could be divided into 2
clusters. Similar to the findings of an earlier report [10],
all Beijing rubella virus strains belong to genotype 1E/
cluster1 and are interspersed with viruses from other
provinces of China. Furthermore, all genotype 1E/clus-
ter1 rubella viruses circulated in different provinces in
mainland China were chronologically well correlated.
This finding suggests that the rubella virus did not
evolve independently in Beijing. Instead, these strains
co-evolved and co-circulated with those from other
provinces in China. Recent studies suggest a very wide
circulation of genotype 1E [8], which may be the most
prevalent contemporary genotype worldwide [8], while
genotype 1E/cluster 1 is unique to China [10]. This
study suggests that the genotype 1E/cluster1 was succes-
sively imported into Russia (2006), United States (2008),
and Japan (2010 and 2011), a phenomenon that may be
related with the frequent international exchanges.
Although the important genetic baseline of Beijing
has already been established, gaps for rubella virological
surveillance still exist; therefore, ongoing molecular
epidemiological surveillance of circulating viruses is
needed, especially when routine vaccination programs
are performed. Vaccination will gradually decrease or
eliminate endemic viruses and allow for the detection of
imported viruses with multiple genotypes.
Methods
Rubella epidemiology data
Data on the number of reported rubella cases and the
annual rubella incidence rates in 1990–2004 were taken
directly from the infectious diseases system of Beijing
and from the case-based rubella surveillance system of
Beijing since 2005 due to rubella cases reporting was in-
troduced into the National Notifiable Disease Reporting
System (NNDRS), and it was the official source of data
on number of reported rubella cases since then. The sur-
veillance system covers all the level of Center for Disease
Prevention and Control (CDC) and medical institutions
in Beijing. The case was reported by clinicians through
the real time online reporting system.
Any patient presents with fever, maculopapular rash, and
cervical, suboccipital or postauricular adenopathy orarthralgia/arthritis was considered as a suspected rubella
case, and when the suspected rubella case with a positive
blood test for rubella-specific Immunoglobulin M (IgM), it
becomes a laboratory-confirmed rubella case. Any infant
less than one year of age with a qualified physician detects
presents at least two of the complications listed in (a)
below or one in (a) and one in (b) was considered as a clin-
ically confirmed CRS case: (a) Cataract, congenital glau-
coma, congenital heart disease, loss of hearing, pigmentary
retinopathy; (b) Purpura, splenomegaly, microcephaly,
mental retardation, meningocephalitis, radiolucent bone
disease, jaundice that begins within 24 hours after birth,
and when a clinically-confirmed CRS case who has a posi-
tive blood test for rubella-specific IgM, it becomes labora-
tory confirmed CRS case.
Specimen collection, virus isolation, and identification
This study did not involve human participants or human
experimentation; the only human materials used were
throat swab samples collected from suspected rubella pa-
tients at the instigation of the Ministry of Health P. R. of
China for public health purposes, and written informed
consent for the use of their clinical samples was obtained
from all patients involved in this study. This study was ap-
proved by the second session of the Ethics Review Com-
mittee of the National Institute for viral disease control
and prevention, Chinese Center for Disease Control and
Prevention. Throat swab samples were collected from
suspected rubella patients within 3 days after rash onset
during the case-based rubella surveillance in 2007–2011.
In addition, a throat swab from a lab-confirmed CRS case
in 2011 was also included in this study.
Isolation of the rubella virus was performed using African
green monkey kidney cells transfected with signaling
lymphocytic activation molecule (Vero/Slam) following the
standard protocol [25]. The presence of viral RNA was
detected using real-time reverse transcription-polymerase
chain reaction (RT-PCR) after RNA extraction from
infected tissue culture cells by using a QIAamp Viral RNA
Extraction Mini Kit (Qiagen, Valencia, CA). The real-time
RT-PCR was performed using 185-bp amplicon primers
and the TaqMan probe as previously described with a One
Step PrimeScriptW RT-PCR Kit (Perfect Real Time; TaKaRa
Biotechnology [Dalian] Co., Ltd.) [26]. The assay was
performed with 25-μL reaction mixtures containing reac-
tion buffer, 12.5 μL of 2× One Step RT-PCR Buffer III, 2.5
U of TaKaRa Ex Taq HS, 0.5 μL of PrimeScript RT Enzyme
Mix II, 0.5 μM each primer, 0.1 μM Taqman probe, and 5
μL of RNA. The thermal cycling was carried out using an
ABI 7500 Thermal Cycler with 42°C for 30 min, 95°C for
2 min, 40 cycles of 95°C for 15 s, and 60°C for 1 min. A re-
action mixture containing water as the template was run
on each plate as a negative control, and positive controls
were also performed. The data were analyzed with 7500
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3–15 was used as the background signal.
WHO standard genotyping window amplification
RT-PCR was performed by using the primer pair from
US CDC (forward primer: 50-AGCGACGCGGCCTG
CTGGGG-30; reverse primer: 50-CGCCCAGGTCTGC
CGGGTCTC-30) to amplify a 944-nt (nt 8633–9577)
product containing the 739-nt genotyping window with
a One Step RNA PCR (AMV) Kit (TaKaRa Biotechnol-
ogy [Dalian] Co., Ltd.). RT-PCR reaction mixture prepar-
ation and thermal cycling was done following the
kit instructions. DNA from RT-PCR-positive reactions
was purified using a QIA Gel Extraction Kit (Qiagen
Valencia, CA) and then determined bidirectionally using
the dye terminator method (BigDye Terminator Version
3.1 Cycle Sequencing Kit; Applied Biosystems, Foster
City, CA, USA) and an ABI 3100 Genetic Analyzer (Ap-
plied Biosystems, Hitachi, Tokyo, Japan). Sequence data
were edited and assembled with Sequencher software
(Version 5.0; GeneCode, Annarbor, MI) to obtain the
739-nt sequence window.
Phylogenetic analysis and the demographic history
estimation
Alignment of the 739-nt sequences of the rubella virus
isolates was performed using BioEdit Sequence Align-
ment Editor Software (version 7.0.9; Tom Hall, North
Carolina State University, Raleigh, NC, USA). Phylogen-
etic trees were constructed using the neighbor-joining
Kimura 2-parameter distance method using the MEGA
program (version 5.0; Sudhir Kumar, Arizona State Uni-
versity, Tempe, AZ, USA) [27]. Bootstrap values > 80%
were considered statistically significant for grouping.
In order to predict the amount of time elapsed be-
tween the introduction of a mutation and the arising of
a particular gene distribution in a population, a BSP, a
retrospective model of population genetics, was used
under both strict and relaxed (uncorrelated lognormal
distributed) clock conditions to estimate the demo-
graphic history with the 739-nt sequence window of the
rubella viruses isolated in Beijing, which allows for esti-
mates of effective population size over time with cred-
ibility intervals at every time depending on errors due to
the phylogeny reconstruction and the stochastic nature
of the coalescent process [28].
Nucleotide sequence accession numbers
The nucleotide sequences of 64 rubella virus strains iso-
lated in this study have been deposited in the GenBank
database under accession numbers JQ979489–JQ979552.
An additional 57 sequences for rubella viruses from 19
provinces other than Beijing in mainland China were re-
trieved from the GenBank database.Abbreviations
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